Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564571 · ClinicalTrials.gov registry record
Artificial Intelligence in Endoscopic Ultrasound
A clinical trial of Pancreatic Cancer and Pancreatic Cyst, sponsored by Orlando Health.
- Recruiting
- Registry status
- 310
- Enrollment target
- 1
- Study location
NCT06564571 is a study of Pancreatic Cancer and Pancreatic Cyst that is actively recruiting participants, run by Orlando Health. The registered enrollment target is 310 participants, below the 392-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06564571, a study of Pancreatic Cancer and Pancreatic Cyst, is actively recruiting participants, sponsored by Orlando Health.
- RECRUITING
- Registry status
- 310 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.
Conditions Studied
Interventions
- DEVICE Patients undergoing endoscopic ultrasound procedures
Study Locations (1)
Florida
- Orlando Health - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2024-01-19 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06564571
The ClinicalTrials.gov registry entry for NCT06564571 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 392-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (21% lower). The listed sponsor is Orlando Health, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patients undergoing endoscopic ultrasound procedures is the first listed.
NCT06564571 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06564571 about?
NCT06564571 is a clinical study titled "Artificial Intelligence in Endoscopic Ultrasound". The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.
What is the current status of trial NCT06564571?
This trial is currently recruiting. The enrollment target is 310 participants. The study started on 2024-01-19. Estimated completion is 2027-12.
What conditions does trial NCT06564571 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Pancreatic Cyst, Pancreas Disease.
What interventions are being tested in trial NCT06564571?
The interventions under investigation include: Patients undergoing endoscopic ultrasound procedures (DEVICE).
Who is sponsoring clinical trial NCT06564571?
This trial is sponsored by Orlando Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06564571 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
RECRUITING · Phase 1
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.